Dr. Christine Franzese
Claim this profileGSK Investigational Site
Affiliated Hospitals
University Of Missouri Hospital
University Of Missouri
Clinical Trials Christine Franzese is currently running
Lebrikizumab
for Rhinosinusitis with Nasal Polyps
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
Recruiting
1 award
Phase 3
5 criteria
Lebrikizumab
for Allergic Rhinitis
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.
Recruiting
1 award
Phase 3
More about Christine Franzese
Clinical Trial Related
1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Christine Franzese has experience with
- Lebrikizumab
- Depemokimab (GSK3511294)
Breakdown of trials Christine Franzese has run
Prophylaxis of Nasal Polyps
Nasal Polyps
Allergic Rhinitis
Hay Fever
Chronic Rhinosinusitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Franzese specialize in?
Christine Franzese focuses on Prophylaxis of Nasal Polyps and Nasal Polyps. In particular, much of their work with Prophylaxis of Nasal Polyps has involved treating patients, or patients who are undergoing treatment.
Is Christine Franzese currently recruiting for clinical trials?
Yes, Christine Franzese is currently recruiting for 2 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Christine Franzese has studied deeply?
Yes, Christine Franzese has studied treatments such as Lebrikizumab, Depemokimab (GSK3511294).
What is the best way to schedule an appointment with Christine Franzese?
Apply for one of the trials that Christine Franzese is conducting.
What is the office address of Christine Franzese?
The office of Christine Franzese is located at: GSK Investigational Site, Columbia, Missouri 65212 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.